English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Sanofi Us

Press release submission | May 8, 2018

SANOFI US: Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients

Carol Ostrow | Oct 7, 2017

Dupixent gains approval as atopic dermatitis treatment in Europe

Nicholas Gueguen | Jul 23, 2017

Study: Dupixent used with topical corticosteroids improves atopic dermatitis

Nicholas Gueguen | Jul 1, 2017

FDA OKs Kevzara for moderate to severe rheumatoid arthritis

Ruth de Jauregui | May 7, 2017

Survey finds majority of rheumatoid arthritis patients living in pain

Robert Hadley | Apr 15, 2017

Toujeo maker touts drug’s ability to lower blood sugar

Erianne Leatherman | Apr 5, 2017

Sanofi Genzyme expands Multiple Myeloma Journey Partners program

Ruth de Jauregui | Apr 2, 2017

FDA approves Dupixent for atopic dermatitis

Trending

Patient Daily | Oct 22, 2025

Chronic Care Policy Alliance backs federal legislation to reform the 340B Drug Pricing Program

Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues

Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'

Patient Daily | Oct 21, 2025

Gulf Coast Breathe Free Physician Assistant on sinus issues: ‘Certain things like dairy seem to increase mucus production’



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily